CSL (CMXHF) Stock Forecast & Price Target

Compare

66 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CMXHF Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

CSL

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CMXHF Stock 12 Month Forecast

Average Price Target

$203.09

▲(36.62%Upside)

Based on 6 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is $203.09 with a high forecast of $207.94 and a low forecast of $197.93. The average price target represents a 36.62% change from the last price of $148.65.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"150":"$150","179":"$179","208":"$208","164.5":"$164.5","193.5":"$193.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":207.936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$207.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":203.09,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$203.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":197.92908,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$197.93</span>\n  </div></div>","useHTML":true}}],"tickPositions":[150,164.5,179,193.5,208],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,167.04,170.18584615384614,173.3316923076923,176.47753846153847,179.62338461538462,182.76923076923077,185.91507692307692,189.06092307692307,192.20676923076923,195.35261538461538,198.49846153846153,201.6443076923077,204.79015384615386,{"y":207.936,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,167.04,169.81307692307692,172.58615384615385,175.35923076923075,178.13230769230768,180.9053846153846,183.67846153846153,186.45153846153846,189.2246153846154,191.99769230769232,194.77076923076925,197.54384615384615,200.31692307692308,{"y":203.09,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,167.04,169.41608307692306,171.79216615384615,174.16824923076922,176.54433230769231,178.92041538461538,181.29649846153845,183.67258153846154,186.0486646153846,188.42474769230768,190.80083076923077,193.17691384615384,195.55299692307693,{"y":197.92908,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":173.49,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.09,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":189.04,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":199.31,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.02,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":191.56,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.87,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":180.7,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.87,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.79,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.05,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.8,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$207.94

Average Price Target$203.09

Lowest Price Target$197.93

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Steven WheenJarden

Jarden

$206.38

Buy

38.84%

Upside

Reiterated

05/18/25

CSL (CMXHF) Receives a Buy from Jarden

David BaileyMorgan Stanley

Morgan Stanley

$203.39

Buy

36.82%

Upside

Reiterated

05/13/25

Morgan Stanley Remains a Buy on CSL (CMXHF)

Davinthra ThillainathanGoldman Sachs

Goldman Sachs

$199.62→$197.93

Buy

33.15%

Upside

Reiterated

05/13/25

CSL (CMXHF) Gets a Buy from Goldman Sachs

Laura SutcliffeUBS

UBS

$201.44

Buy

35.51%

Upside

Reiterated

05/12/25

Analysts Offer Insights on Healthcare Companies: Radnet (NASDAQ: RDNT), CSL (Other OTC: CMXHF) and BioMarin Pharmaceutical (NASDAQ: BMRN)

Unknown AnalystOrd Minnett

Not Ranked

Ord Minnett

$201.44

Buy

35.51%

Upside

Reiterated

05/08/25

David StantonJefferies

Jefferies

$216.38→$207.94

Buy

39.88%

Upside

Reiterated

04/16/25

Jefferies Keeps Their Buy Rating on CSL (CMXHF)

Ed HenningCLSA

CLSA

$218.98→$214.43

Buy

44.25%

Upside

Reiterated

02/12/25

CSL Ltd. (CSL:AU) (CMXHF) PT Lowered to AUD330 at CLSACLSA analyst Ed Henning lowered the price target on CSL Ltd. (CSL:AU) (OTC: CMXHF) to AUD330.00 (from AUD337.00) while maintaining a Outperform (2) rating.

David LowJ.P. Morgan

J.P. Morgan

$211.19→$204.69

Buy

37.70%

Upside

Reiterated

02/12/25

CSL Ltd. (CSL:AU) (CMXHF) PT Lowered to AUD315 at JPMorganJPMorgan analyst David Low lowered the price target on CSL Ltd. (CSL:AU) (OTC: CMXHF) to AUD315.00 (from AUD325.00) while maintaining a Overweight rating.

Shane StoreyWilsons

Wilsons

$162.45

Hold

9.28%

Upside

Reiterated

02/11/25

Wilsons Sticks to Their Hold Rating for CSL (CMXHF)

Derek JellinekMorgans

Morgans

$213.95

Buy

43.93%

Upside

Reiterated

02/11/25

CSL (CMXHF) Gets a Buy from Morgans

Christine TrinhMacquarie

Macquarie

$217.03→$234.12

Buy

57.50%

Upside

Reiterated

02/11/25

Macquarie Reiterates Outperform Rating on CSL Ltd. (CSL:AU) (CMXHF)Macquarie analyst Christine Trinh reiterated an Outperform rating and AUD360.30 price target on CSL Ltd. (CSL:AU) (OTC: CMXHF).

Craig Wong-PanRBC Capital

RBC Capital

$185.84→$181.29

Hold

21.96%

Upside

Reiterated

02/11/25

RBC Capital Remains a Hold on CSL (CMXHF)

Mathieu ChevrierCiti

Citi

$224.18→$217.68

Buy

46.44%

Upside

Reiterated

02/11/25

Citi Reaffirms Their Buy Rating on CSL (CMXHF)

Thomas WakimBell Potter

Bell Potter

$217.68

Buy

46.44%

Upside

Reiterated

02/11/25

CSL (CMXHF) Gets a Buy from Bell Potter

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Steven WheenJarden

Jarden

$206.38

Buy

38.84%

Upside

Reiterated

05/18/25

CSL (CMXHF) Receives a Buy from Jarden

David BaileyMorgan Stanley

Morgan Stanley

$203.39

Buy

36.82%

Upside

Reiterated

05/13/25

Morgan Stanley Remains a Buy on CSL (CMXHF)

Davinthra ThillainathanGoldman Sachs

Goldman Sachs

$199.62→$197.93

Buy

33.15%

Upside

Reiterated

05/13/25

CSL (CMXHF) Gets a Buy from Goldman Sachs

Laura SutcliffeUBS

UBS

$201.44

Buy

35.51%

Upside

Reiterated

05/12/25

Analysts Offer Insights on Healthcare Companies: Radnet (NASDAQ: RDNT), CSL (Other OTC: CMXHF) and BioMarin Pharmaceutical (NASDAQ: BMRN)

Unknown AnalystOrd Minnett

Not Ranked

Ord Minnett

$201.44

Buy

35.51%

Upside

Reiterated

05/08/25

David StantonJefferies

Jefferies

$216.38→$207.94

Buy

39.88%

Upside

Reiterated

04/16/25

Jefferies Keeps Their Buy Rating on CSL (CMXHF)

Ed HenningCLSA

CLSA

$218.98→$214.43

Buy

44.25%

Upside

Reiterated

02/12/25

David LowJ.P. Morgan

J.P. Morgan

$211.19→$204.69

Buy

37.70%

Upside

Reiterated

02/12/25

Shane StoreyWilsons

Wilsons

$162.45

Hold

9.28%

Upside

Reiterated

02/11/25

Wilsons Sticks to Their Hold Rating for CSL (CMXHF)

Derek JellinekMorgans

Morgans

$213.95

Buy

43.93%

Upside

Reiterated

02/11/25

CSL (CMXHF) Gets a Buy from Morgans

Christine TrinhMacquarie

Macquarie

$217.03→$234.12

Buy

57.50%

Upside

Reiterated

02/11/25

Macquarie Reiterates Outperform Rating on CSL Ltd. (CSL:AU) (CMXHF)Macquarie analyst Christine Trinh reiterated an Outperform rating and AUD360.30 price target on CSL Ltd. (CSL:AU) (OTC: CMXHF).

Craig Wong-PanRBC Capital

RBC Capital

$185.84→$181.29

Hold

21.96%

Upside

Reiterated

02/11/25

RBC Capital Remains a Hold on CSL (CMXHF)

Mathieu ChevrierCiti

Citi

$224.18→$217.68

Buy

46.44%

Upside

Reiterated

02/11/25

Citi Reaffirms Their Buy Rating on CSL (CMXHF)

Thomas WakimBell Potter

Bell Potter

$217.68

Buy

46.44%

Upside

Reiterated

02/11/25

CSL (CMXHF) Gets a Buy from Bell Potter

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

1 Month

xxx

Success Rate

8/15 ratings generated profit

Average Return

-1.75%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of -1.75% per trade.

3 Months

xxx

Success Rate

4/11 ratings generated profit

Average Return

+0.08%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 36.36% of your transactions generating a profit, with an average return of +0.08% per trade.

1 Year

David BaileyMorgan Stanley

Success Rate

4/11 ratings generated profit

Average Return

-4.09%

reiterated a buy rating last month

Copying David Bailey's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -4.09% per trade.

2 Years

xxx

Success Rate

3/13 ratings generated profit

Average Return

-6.60%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 23.08% of your transactions generating a profit, with an average return of -6.60% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CMXHF Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CMXHF has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CMXHF average Analyst price target in the past 3 months is 203.09.

Each month's total comprises the sum of three months' worth of ratings.

CMXHF Financial Forecast

CMXHF Earnings Forecast

Next quarter’s earnings estimate for CMXHF is $2.24 with a range of $2.14 to $2.35. The previous quarter’s EPS was $4.29. CMXHF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year CMXHF has Outperformed its overall industry.

CMXHF Sales Forecast

Next quarter’s sales forecast for CMXHF is $7.12B with a range of $6.77B to $7.44B. The previous quarter’s sales results were $8.20B. CMXHF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year CMXHF has Preformed in-line its overall industry.

CMXHF Stock Forecast FAQ

What is CMXHF’s average 12-month price target, according to analysts?

Based on analyst ratings, CSL’s 12-month average price target is 203.09.

What is CMXHF’s upside potential, based on the analysts’ average price target?

CSL has 36.62% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CMXHF a Buy, Sell or Hold?

CSL has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is CSL’s price target?

The average price target for CSL is 203.09. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $207.94 ,the lowest forecast is $197.93. The average price target represents 36.62% Increase from the current price of $148.65.

What do analysts say about CSL?

CSL’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of CMXHF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

CSL (CMXHF) Stock Forecast & Price Target

CMXHF Analyst Ratings

CMXHF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CSL

CMXHF Analyst Recommendation Trends

CMXHF Financial Forecast

CMXHF Earnings Forecast

CMXHF Sales Forecast

CMXHF Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts